The Ca

Ca2+/calmodulin-dependent protein kinase II cardiovascular disease cell biology left ventricular hypertrophy mechanosensitive channels medicine mouse

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
30 06 2021
Historique:
received: 15 01 2021
accepted: 20 06 2021
entrez: 30 6 2021
pubmed: 1 7 2021
medline: 9 10 2021
Statut: epublish

Résumé

Pathological left ventricular hypertrophy (LVH) occurs in response to pressure overload and remains the single most important clinical predictor of cardiac mortality. The molecular pathways in the induction of pressure overload LVH are potential targets for therapeutic intervention. Current treatments aim to remove the pressure overload stimulus for LVH, but do not completely reverse adverse cardiac remodelling. Although numerous molecular signalling steps in the induction of LVH have been identified, the initial step by which mechanical stretch associated with cardiac pressure overload is converted into a chemical signal that initiates hypertrophic signalling remains unresolved. In this study, we show that selective deletion of transient receptor potential melastatin 4 (TRPM4) channels in mouse cardiomyocytes results in an approximately 50% reduction in the LVH induced by transverse aortic constriction. Our results suggest that TRPM4 channel is an important component of the mechanosensory signalling pathway that induces LVH in response to pressure overload and represents a potential novel therapeutic target for the prevention of pathological LVH.

Identifiants

pubmed: 34190686
doi: 10.7554/eLife.66582
pii: 66582
pmc: PMC8245133
doi:
pii:

Substances chimiques

TRPM Cation Channels 0
TRPM4 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Health and Medical Research Council
ID : APP1108013
Organisme : National Health and Medical Research Council
ID : APP1135974
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G0E0317N
Organisme : KU Leuven
ID : TRPLe
Organisme : NSW Health
ID : EMCRFellowship

Informations de copyright

© 2021, Guo et al.

Déclaration de conflit d'intérêts

YG, ZY, JW, HG, SK, SI, AC, SH, SP, AP, CC, RG, RV, MF, BM No competing interests declared

Références

Am J Physiol. 1994 Jun;266(6 Pt 2):H2468-75
pubmed: 8024008
J Clin Invest. 2000 May;105(10):1395-406
pubmed: 10811847
Circulation. 2004 Apr 6;109(13):1580-9
pubmed: 15066961
Hypertension. 2006 Oct;48(4):587-94
pubmed: 16966582
Circ Res. 2013 Jun 21;113(1):16-9
pubmed: 23788503
J Mol Cell Cardiol. 2011 Mar;50(3):460-70
pubmed: 21111744
Proteins. 2009 Jul;76(1):47-61
pubmed: 19089983
J Mol Cell Cardiol. 2013 Jun;59:11-9
pubmed: 23416167
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):931-6
pubmed: 10639182
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2342-7
pubmed: 19179290
Circ Res. 2004 Jan 9;94(1):110-8
pubmed: 14656927
Nat Rev Cardiol. 2019 Jun;16(6):361-378
pubmed: 30683889
Physiol Rev. 1999 Jan;79(1):215-62
pubmed: 9922372
Cardiovasc Res. 2001 Aug 1;51(2):194-7
pubmed: 11470457
Circ Res. 2000 Oct 27;87(9):731-8
pubmed: 11055975
JCI Insight. 2017 Sep 7;2(17):
pubmed: 28878124
Sci Rep. 2020 Sep 18;10(1):15318
pubmed: 32948799
Nature. 1997 Apr 24;386(6627):855-8
pubmed: 9126747
Hypertension. 2002 Nov;40(5):660-6
pubmed: 12411459
Front Endocrinol (Lausanne). 2012 Aug 20;3:99
pubmed: 22934090
Circ Res. 2016 Jan 22;118(2):311-29
pubmed: 26838316
Circulation. 2010 Dec 21;122(25):2727-35
pubmed: 21173361
J Card Fail. 2020 Jul;26(7):599-609
pubmed: 32147520
Circulation. 2014 Oct 7;130(15):1262-73
pubmed: 25124496
N Engl J Med. 1990 May 31;322(22):1561-6
pubmed: 2139921
Cardiovasc Res. 2015 Oct 1;108(1):21-30
pubmed: 26272755
J Physiol. 2016 Jan 15;594(2):295-306
pubmed: 26548780
J Physiol. 2004 Jul 1;558(Pt 1):75-83
pubmed: 15121803
Annu Rev Physiol. 2008;70:23-49
pubmed: 17988210
J Biol Chem. 2004 Oct 15;279(42):43392-402
pubmed: 15297455
Pharmacol Ther. 2008 Jun;118(3):337-51
pubmed: 18508125
IUBMB Life. 2011 Oct;63(10):847-55
pubmed: 21901815
Nat Rev Mol Cell Biol. 2013 Jan;14(1):38-48
pubmed: 23258295
J Biol Chem. 2005 Feb 25;280(8):6423-33
pubmed: 15590641
Nat Cell Biol. 2004 Jun;6(6):499-506
pubmed: 15146194
Science. 1998 Jan 9;279(5348):227-30
pubmed: 9422695
Proc Natl Acad Sci U S A. 1987 Aug;84(16):5710-4
pubmed: 3475699
J Biol Chem. 2004 Feb 6;279(6):4782-93
pubmed: 14597618
Annu Rev Physiol. 2002;64:289-311
pubmed: 11826271
Pflugers Arch. 2008 Mar;455(6):1097-103
pubmed: 17957383
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2859-64
pubmed: 18287024
J Muscle Res Cell Motil. 2017 Feb;38(1):3-16
pubmed: 28224334
J Clin Invest. 2013 Jan;123(1):37-45
pubmed: 23281408
Cells. 2018 Jun 15;7(6):
pubmed: 29914130
Nat Rev Cardiol. 2018 Jul;15(7):387-407
pubmed: 29674714
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):7000-5
pubmed: 20351294
Cell Rep. 2016 Nov 8;17(7):1739-1746
pubmed: 27829145
Cell Rep. 2019 Oct 1;29(1):1-12
pubmed: 31577940
Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10140-5
pubmed: 9707614
PLoS One. 2015 May 08;10(5):e0125503
pubmed: 25955826
Circ Res. 2009 Aug 14;105(4):316-25
pubmed: 19608982
Biochem Biophys Res Commun. 2004 Oct 1;322(4):1178-91
pubmed: 15336966
Arch Toxicol. 2015 Sep;89(9):1401-38
pubmed: 25708889
Nature. 2008 Feb 21;451(7181):919-28
pubmed: 18288181
Nat Commun. 2020 Sep 4;11(1):4416
pubmed: 32887881
Front Cell Dev Biol. 2021 Feb 15;9:639509
pubmed: 33659256
Cardiovasc Res. 2015 Mar 1;105(3):330-9
pubmed: 25600961
J Biol Chem. 2003 Aug 15;278(33):30813-20
pubmed: 12799367
J Cell Sci. 2019 Dec 10;132(23):
pubmed: 31722978
Cell. 1998 Apr 17;93(2):215-28
pubmed: 9568714
Circ Res. 2014 Jan 17;114(2):283-94
pubmed: 24226423
Prog Biophys Mol Biol. 2021 Jan;159:105-117
pubmed: 33031824
Channels (Austin). 2017 Jan 2;11(1):5-7
pubmed: 27437722
Channels (Austin). 2010 Nov-Dec;4(6):447-52
pubmed: 21139421
Circ Res. 2011 Jan 21;108(2):265-72
pubmed: 21252153
J Clin Invest. 2006 Jul;116(7):1853-64
pubmed: 16767219
Sci Rep. 2016 Jan 20;6:19352
pubmed: 26785754
Basic Res Cardiol. 2015;110(4):43
pubmed: 26043922
Circ Res. 2011 Apr 1;108(7):884-97
pubmed: 21454796
Cell. 2002 May 3;109(3):397-407
pubmed: 12015988

Auteurs

Yang Guo (Y)

Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Sydney, Australia.
Cardiac Physiology and Transplantation Division, Victor Chang Cardiac Research Institute, Sydney, Australia.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia.

Ze-Yan Yu (ZY)

Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Sydney, Australia.
Cardiac Physiology and Transplantation Division, Victor Chang Cardiac Research Institute, Sydney, Australia.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia.

Jianxin Wu (J)

Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Sydney, Australia.

Hutao Gong (H)

Cardiac Physiology and Transplantation Division, Victor Chang Cardiac Research Institute, Sydney, Australia.

Scott Kesteven (S)

Cardiac Physiology and Transplantation Division, Victor Chang Cardiac Research Institute, Sydney, Australia.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia.

Siiri E Iismaa (SE)

Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Sydney, Australia.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia.

Andrea Y Chan (AY)

Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Sydney, Australia.

Sara Holman (S)

Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Sydney, Australia.

Silvia Pinto (S)

Laboratory of Ion Channel Research, Department of Molecular and Cellular Medicine, Katholieke Universiteit Leuven, Leuven, Belgium.
TRP Research Platform Leuven (TRPLe), Katholieke Universiteit Leuven, Leuven, Belgium.

Andy Pironet (A)

Laboratory of Ion Channel Research, Department of Molecular and Cellular Medicine, Katholieke Universiteit Leuven, Leuven, Belgium.
TRP Research Platform Leuven (TRPLe), Katholieke Universiteit Leuven, Leuven, Belgium.

Charles D Cox (CD)

Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Sydney, Australia.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia.

Robert M Graham (RM)

Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Sydney, Australia.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia.

Rudi Vennekens (R)

Laboratory of Ion Channel Research, Department of Molecular and Cellular Medicine, Katholieke Universiteit Leuven, Leuven, Belgium.
TRP Research Platform Leuven (TRPLe), Katholieke Universiteit Leuven, Leuven, Belgium.

Michael P Feneley (MP)

Cardiac Physiology and Transplantation Division, Victor Chang Cardiac Research Institute, Sydney, Australia.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia.
Department of Cardiology, St Vincent's Hospital, Sydney, Australia.

Boris Martinac (B)

Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Sydney, Australia.
St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH